Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Management in general practice of hypertensive patients poorly controlled with a fixed-dose renin–angiotensin system inhibitor and diuretic combination: results from a French national survey

Journal of Human Hypertension volume 20, pages 407–418 (2006)Cite this article

Abstract

High rates of uncontrolled hypertensives have been reported in France as well as in other countries, partly owing to an inadequate management of hypertension by clinicians. The objectives of the study were (1) to describe the therapeutic decisions faced by general practitioners (GP) in hypertensives not controlled by fixed-dose combination antihypertensive therapy with a renin–angiotensin system (RAS) inhibitor and a diuretic (D) and (2) to evaluate the frequency with which ambulatory blood pressure monitoring (ABPM) is used in these patients. Each GP had to include five uncontrolled hypertensives on fixed-dose RAS inhibitor and D combination. A total of 2118 GPs included 9551 patients; 8643 patients were receiving at least one of the two drugs at a low dose (group 1) and the remaining 908 patients were receiving high doses of both drugs (group 2). The most common therapeutic choice was that of a new combination, either a fixed-dose in one pill or with separate preparations: 65% (n=5621) in group 1 and 56% (n=505) in group 2. An increase in dose was chosen in 28% of patients in group 1 (n=2467) and continuation of treatment without modification in 27% of patients in group 2 (n=242). A third active principle was only added in 2.5% of patients in group 1 (n=219) and 11% in group 2 (n=103). Ambulatory blood pressure monitoring was employed in 25% of patients (n=2413). An improvement in hypertension management should be expected from the implementation of the 2005 French guidelines.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  1. Girerd X, Mourad JJ, Vaisse B, Poncelet P, Mallion JM, Herpin D . Estimation du nombre des sujets traités pour une HTA, un diabète ou une hyperlipidémie en France: étude FLAHS 2002. Arch Mal Coeur 2003; 96: 750–753.

    CAS  PubMed  Google Scholar 

  2. Frerot L, Le Fur P, Le Pape A, Sermet C . L'hypertension artérielle en France: prévalence et prise en charge thérapeutique. Bulletin d'information en économie de la santé. Questions d'économie de la santé. CREDES Septembre 1999; 22: 1–9.

    Google Scholar 

  3. Chamontin B, Poggi L, Lang T, Menard J, Chevalier H, Gallois H et al. Prevalence, treatment, and control of hypertension in the French population: data from a survey on high blood pressure in general practice, 1994. Am J Hypertens 1998; 11: 759–762.

    Article  CAS  Google Scholar 

  4. Mounier-Vehier C, Amah G, Covillard J, Jaboureck O, Phan TM . Prise en charge de l'HTA essentielle et du niveau de risqué cardiovasculaire. Observatoire en médecine générale: enquête nationale PHENOMEN. Arch Mal Coeur Vaiss 2002; 95: 667–672.

    CAS  PubMed  Google Scholar 

  5. Amar J, Vaur L, Perret M, Bailleau C, Etienne S, Chamontin B et al. Hypertension in high-risk patients: beware of the underuse of effective combination therapy (results of the PRATIK study). J Hypertens 2002; 20: 779–784.

    Article  Google Scholar 

  6. Agence Nationale d'Accréditation et d'Evaluation en Santé (ANAES). Prise en Charge des Patients Adultes Atteints d'hypertension Artérielle Essentielle. ANAES: Paris, 2000.

  7. Tilly B, Guilhot J, Slanave B, Garrigue P, Fender P, Allemand H . Enquête nationale de l'assurance maladie sur la prise en charge médicale de l'hypertension artérielle sévère exonérée du ticket modérateur en France en 1999. Program Natl Santé Publique 2000, 1–5.

  8. Heart Outcomes Prevention Evaluation Study Investigators. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Lancet 2000; 355: 253–259.

  9. Hansson L, Lindholm LH, Niskanen L, Lanke J, Hedner T, Niklason A et al. Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomized trial. Lancet 1999; 353: 611–616.

    Article  CAS  Google Scholar 

  10. Nelson MR, Reid CM, Krum H, Ryan P, Wing LM, McNeil JJ et al. Management Committee, Second Australian National Blood Pressure Study. Short-term predictors of maintenance of normotension after withdrawal of antihypertensive drugs in the second Australian National Blood Pressure Study (ANBP2). Am J Hypertens 2003; 16: 39–45.

    Article  Google Scholar 

  11. Dahlof B, Devereux RB, Kjeldsen SE, Julius S, Beevers G, de Faire U et al. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 2002; 359: 995–1003.

    Article  CAS  Google Scholar 

  12. Julius S, Kjeldsen SE, Weber M, Brunner HR, Ekman S, Hansson L et al. Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial. Lancet 2004; 363: 2022–2031.

    Article  CAS  Google Scholar 

  13. Mallion JM, Asmar R, Poggi L, Safar M, Andre JL, Balansard P et al. Pression artérielle – Automesure. Recommandations. Société Française d'Hypertension Artérielle – Groupe de la Mesure. Arch Mal Coeur Vaiss 1989; 82: 1001–1005.

    CAS  PubMed  Google Scholar 

  14. Marques-Vidal P, Arveiler D, Amouyel P, Bingham A, Ferrieres J . Sex differences in awareness and control of hypertension in France. J Hypertens 1997; 15: 1205–1210.

    Article  CAS  Google Scholar 

  15. Lang T, de Gaudemaris R, Chatellier G, Hamici L, Diene E, Epidemiology Group of the Societe Francaise d'Hypertension Arterielle and the IHPAF Working Physicians Group. Prevalence and therapeutic control of hypertension in 30 000 subjects in the workplace. Hypertension 2001; 38: 449–454.

    Article  CAS  Google Scholar 

  16. Colhoun HM, Dong W, Poulter NR . Blood pressure screening, management and control in England: results from the health survey for England 1994. J Hypertens 1998; 16: 747–752.

    Article  CAS  Google Scholar 

  17. Smith WC, Lee AJ, Crombie IK, Tunstall-Pedoe H . Control of blood pressure in Scotland: the rule of halves. BMJ 1990; 300: 981–983.

    Article  CAS  Google Scholar 

  18. Hajjar I, Kotchen TA . Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988–2000. JAMA 2003; 290: 199–206.

    Article  Google Scholar 

  19. Ragot S, Sosner P, Herpin D . HTA non contrôlées: intérêt pharmaco-économique d'un bilan hospitalier. Arch Mal Coeur Vaiss 2002; 95: 733–737.

    CAS  PubMed  Google Scholar 

  20. Asmar R, Vol S, Pannier B, Brisac AM, Tichet J, El Hasnaoui A . High blood pressure and associated cardiovascular risk factors in France. J Hypertens 2001; 19: 1727–1732.

    Article  CAS  Google Scholar 

  21. Law MR, Wald NJ, Morris JK, Jordan RE . Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials. BMJ 2003; 326: 1427–1434.

    Article  CAS  Google Scholar 

  22. Morgan TO, Anderson AI, MacInnis RJ . ACE inhibitors, beta-blockers, calcium blockers, and diuretics for the control of systolic hypertension. Am J Hypertens 2001; 14: 241–247.

    Article  CAS  Google Scholar 

  23. Magee PF, Freis ED . Is low-dose hydrochlorothiazide effective? Hypertension 1986; 8: 135–139.

    Article  Google Scholar 

  24. Jounela AJ, Lilja M, Lumme J, Morlin C, Hoyem A, Wessel-Aas T et al. Relation between low dose of hydrochlorothiazide, antihypertensive effect and adverse effects. Blood Press 1994; 3: 231–235.

    Article  CAS  Google Scholar 

  25. Girerd X, Denolle T, Yau C, Fiquet B, Brunel P, Moulin B et al. Automated office and home phone-transmitted blood pressure recordings in uncontrolled hypertension treated with valsartan and hydrochlorothiazide. Blood Press 2004; S2: 18–24.

    Article  Google Scholar 

  26. Dickerson JE, Hingorani AD, Ashby MJ, Palmer CR, Brown MJ . Optimisation of antihypertensive treatment by crossover rotation of four major classes. Lancet 1999; 353: 2008–2013.

    Article  CAS  Google Scholar 

  27. Williams B, Poulter NR, Brown MJ, Davis M, McInnes GT, Potter JF et al. British Hypertension Society guidelines for hypertension management 2004 (BHS-IV): summary. BMJ 2004; 328: 634–640.

    Article  Google Scholar 

  28. Bloom BS . Continuation of initial antihypertensive medication after 1 year of therapy. Clin Ther 1998; 20: 671–681.

    Article  CAS  Google Scholar 

  29. Bourgault C, Senecal M, Brisson M, Marentette MA, Gregoire JP . Persistence and discontinuation patterns of antihypertensive therapy among newly treated patients: a population-based study. J Hum Hypertens 2005; 19: 607–613.

    Article  CAS  Google Scholar 

  30. Chou CC, Lee MS, Ke CH, Chuang MH . Factors influencing the switch in the use of antihypertensive medications. Int J Clin Pract 2005; 59: 85–91.

    Article  Google Scholar 

  31. Borenstein J, Whyte JL, Badamgarav E, Vogel D, Deutsch S, Weingarten S et al. Physician practice patterns in the treatment of isolated systolic hypertension in a primary care setting. J Clin Hypertens (Greenwich) 2002; 4: 93–100.

    Article  Google Scholar 

  32. Hansson L, Zanchetti A, Carruthers SG, Dahlof B, Elmfeldt D, Julius S et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group. Lancet 1998; 351: 1755–1762.

    Article  CAS  Google Scholar 

  33. UK Prospective Diabetes Study Group. Cost effectiveness analysis of improved blood pressure control in hypertensive patients with type 2 diabetes: UKPDS 40. BMJ 1998; 317: 720–726.

  34. Phillips LS, Branch WT, Cook CB, Doyle JP, El-Kebbi IM, Gallina Dl et al. Clinical inertia. Ann Intern Med 2001; 135: 825–834.

    Article  CAS  Google Scholar 

  35. Toyoshima H, Takahashi K, Akera T . The impact of side effects on hypertension management: a Japanese survey. Clin Ther 1997; 19: 1458–1469.

    Article  CAS  Google Scholar 

  36. Chen K, Chiou CF, Plauschinat CA, Frech F, Harper A, Dubois R . Patient satisfaction with antihypertensive therapy. J Hum Hypertens 2005; 19: 793–799.

    Article  CAS  Google Scholar 

  37. Eisen SA, Miller DK, Woodward RS, Spitznagel E, Przybeck TR . The effect of prescribed daily dose frequency on patient medication compliance. Arch Intern Med 1990; 150: 1881–1884.

    Article  CAS  Google Scholar 

  38. Mallion JM, Genes N, Vaur L, Clerson P, Vaisse B, Bobrie G et al. Blood pressure levels, risk factors and antihypertensive treatments: lessons from the SHEAF study. J Hum Hypertens 2001; 15: 841–848.

    Article  CAS  Google Scholar 

  39. Brown MA, Buddle ML, Martin A . Is resistant hypertension really resistant? Am J Hypertens 2001; 14: 1263–1269.

    Article  CAS  Google Scholar 

  40. Verdecchia P, Porcellati C, Schillaci G, Borgioni C, Ciucci A, Battistelli M et al. Ambulatory blood pressure. An independent predictor of prognosis in essential hypertension. Hypertension 1994; 24: 793–801.

    Article  CAS  Google Scholar 

  41. Clement DL, De Buyzere ML, De Bacquer DA, de Leeuw PW, Duprez DA, Fagard RH et al. Office versus Ambulatory Pressure Study Investigators. Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension. N Engl J Med 2003; 348: 2407–2415.

    Article  Google Scholar 

  42. Mancia G, Parati G . Ambulatory blood pressure monitoring and organ damage. Hypertension 2000; 36: 894–900.

    Article  CAS  Google Scholar 

  43. Haute Autorité de Santé (HAS). Prise en Charge des Patients Adultes Atteints d'hypertension Artérielle Essentielle – Actualisation 2005. HAS: Paris, 2005 (www.has-sante.fr).

Download references

Acknowledgements

We are indebted to Simon Jarman for his linguistic assistance.

Author information

Authors and Affiliations

  1. Clinic Research Centre, CHU La Milétrie, Poitiers and University Institute of Public Health, Faculty of Medicine and Pharmacy, Poitiers, France

    S Ragot

  2. Department of Cardiology, CHU La Milétrie, Poitiers, France

    P Sosner & D Herpin

  3. Novartis Pharma SAS, Rueil-Malmaison, France

    C Yau & P Brunel

Authors
  1. S Ragot
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P Sosner
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C Yau
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. P Brunel
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. D Herpin
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to S Ragot.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ragot, S., Sosner, P., Yau, C. et al. Management in general practice of hypertensive patients poorly controlled with a fixed-dose renin–angiotensin system inhibitor and diuretic combination: results from a French national survey. J Hum Hypertens 20, 407–418 (2006). https://doi.org/10.1038/sj.jhh.1002000

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.jhh.1002000

Keywords

This article is cited by

Search

Advanced search

Quick links